BioSupplyNet.com – A directory of Life Science companies and their products

Featured Sale

Limited time offer on
catalog antibodies for
AbD Serotec's
North American customers

Featured Promotion

Request your free sample here

E-Mail:

Password:

Remember Me

Not Registered?

Forgot Your Password?

Request Product Information

Altogen Biosystems
848 Rainbow Blvd #823
Las Vegas, NV 89107 United States
Phone: (702) 989-0841
Fax: (702) 989-0841
Website: www.altogen.com
E-mail: orders@altogen.com

Altogen Biosystems is a life sciences company dedicated to the development and manufacturing of the cell line specific transfection reagents. Pre-optimized transfection kits enable efficient delivery of plasmid DNA, mRNA, siRNA, and microRNA into broad range of cell types and primary cells. Advanced formulation of reagents and peculiar design of the transfection protocols provides reproducible results. Transfection agents are serum compatible, induce low toxicity, and can be used for co-transfection experiments and high-throughput applications.

Transfection, an introduction of foreign DNA or RNA molecules into cultured cells, is now a commonly used method in biological laboratories for studying gene function, modulation of gene expression, biochemical mapping, mutational analysis, and protein production. Scientists use various carrier molecules to enable non-viral gene delivery of such molecules as plasmid DNA (pDNA), messenger RNA (mRNA), short interfering RNA (siRNA), and microRNA (miRNA) into cancer cell lines and primary cells. Unfortunately, there is no single delivery method or transfection agent that can be applied to all types of cells: transfection efficiencies vary dramatically depending on which cell type is being transfected, and what reagent is used. Altogen Biosystems offers pre-optimized transfection technologies for a specific cell line by applying expertise in combinatorial chemistry, molecular biology, and cell biology.

Successfully transfected cell lines include:
Aortic smooth muscle cells (ASMC), human lung carcinoma cells (A549), human hepatocellular carcinoma cells (HepG2), human prostate cancer cells (DU145), mouse embryonic stem cells (MES), human rhabdomyosarcoma cells (A204), human epithelial kidney cells (HEK293), hamster ovary epithelial cells (CHO), human trachea epithelium cells (CFPEo), human hypopharyngeal carcinoma cells (FaDu), human coronary artery endothelial cells (HCAEC), human cortical neuronal cells (HCN-1A), human cervix adenocarcinoma cells (HeLa), umbilical vein endothelial cells (HUVEC), breast cancer cells (MDA-MB), murine embryonic fibroblast cells (MEF), human diploid fibroblast cells (MRC-5), rat pheochromocytoma cells (PC12), human adrenocortical carcinoma cells (SW-13), and others.

View Product Categories

Product: HepG2 Transfection Reagent

Catalog #: 2067

Price: US$195

Link: http://www.altogen.com

Benefits: Pre-Optimized Transfection Kits for Over 60 Cell Lines and Primary Cells

Description:

Pre-Optimized Transfection Protocols
- Low cellular toxicity
- High transfection efficiency
- Co-transfection applications
- Adapted for high throughput screening
Cell Line Specific Reagents
- Over 60 Transfection Reagents
- Optimized delivery of DNA, mRNA, siRNA, and microRNA
- Enhanced gene silencing using RNAi
- Compatible with standard and reverse transfection methods
HepG2 Transfection Reagent
- Optimized for delivery of DNA, mRNA, siRNA, and microRNA into human hepatocellular carcinoma cells
- Works in presence of serum
- Applicable for transient and stable transfection
- Enhanced siRNA and shRNA transfection
- Provides reproducible results